Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults
- PMID: 25964507
- PMCID: PMC4621251
- DOI: 10.1093/infdis/jiv274
Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults
Abstract
Background: Impaired cardiac function persists in the era of effective human immunodeficiency virus (HIV) therapy, although the etiology is unclear. We used magnetic resonance imaging (MRI) to measure intramyocardial lipid levels and fibrosis as possible contributors to HIV-associated myocardial dysfunction.
Methods: A cross-sectional study of 95 HIV-infected and 30 matched-healthy adults, without known cardiovascular disease (CVD) was completed. Intramyocardial lipid levels, myocardial fibrosis, and cardiac function (measured on the basis of strain) were quantified by MRI.
Results: Systolic function was significantly decreased in HIV-infected subjects as compared to controls (mean radial strain [±SD], 21.7 ± 8.6% vs 30.5 ± 14.2%; P = .004). Intramyocardial lipid level and fibrosis index were both increased in HIV-infected subjects as compared to controls (P ≤ .04 for both) and correlated with the degree of myocardial dysfunction measured by strain parameters. Intramyocardial lipid levels correlated positively with antiretroviral therapy duration and visceral adiposity. Further, impaired myocardial function was strongly correlated with increased monocyte chemoattractant protein 1 levels (r = 0.396, P = .0002) and lipopolysaccharide binding protein levels (r = 0.25, P = .02).
Conclusions: HIV-infected adults have reduced myocardial function as compared to controls in the absence of known CVD. Decreased cardiac function was associated with abnormal myocardial tissue composition characterized by increased lipid levels and diffuse myocardial fibrosis. Metabolic alterations related to antiretroviral therapy and chronic inflammation may be important targets for optimizing long-term cardiovascular health in HIV-infected individuals.
Keywords: HIV; antiretroviral therapy; intramyocardial lipid; magnetic resonance spectroscopy; myocardial strain.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Figures
Similar articles
-
Immune Dysregulation in Myocardial Fibrosis, Steatosis, and Heart Failure: Current Insights from HIV and the General Population.Curr HIV/AIDS Rep. 2021 Feb;18(1):63-72. doi: 10.1007/s11904-020-00536-9. Epub 2021 Jan 12. Curr HIV/AIDS Rep. 2021. PMID: 33433816 Review.
-
Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients.Circulation. 2013 Aug 20;128(8):814-22. doi: 10.1161/CIRCULATIONAHA.113.001719. Epub 2013 Jul 1. Circulation. 2013. PMID: 23817574
-
HIV-1-Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema.Circ Cardiovasc Imaging. 2016 Mar;9(3):e004430. doi: 10.1161/CIRCIMAGING.115.004430. Circ Cardiovasc Imaging. 2016. PMID: 26951605
-
Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients.Circ Cardiovasc Imaging. 2016 Mar;9(3):e004091. doi: 10.1161/CIRCIMAGING.115.004091. Circ Cardiovasc Imaging. 2016. PMID: 26951603
-
Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context.Circulation. 2023 Jan 3;147(1):83-100. doi: 10.1161/CIRCULATIONAHA.122.057443. Epub 2022 Dec 28. Circulation. 2023. PMID: 36576956 Review.
Cited by
-
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.Circulation. 2019 Jul 9;140(2):e98-e124. doi: 10.1161/CIR.0000000000000695. Epub 2019 Jun 3. Circulation. 2019. PMID: 31154814 Free PMC article. Review.
-
Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV.J Acquir Immune Defic Syndr. 2018 May 1;78(1):105-110. doi: 10.1097/QAI.0000000000001644. J Acquir Immune Defic Syndr. 2018. PMID: 29419569 Free PMC article. Clinical Trial.
-
Diffuse myocardial fibrosis is uncommon in people with perinatally acquired human immunodeficiency virus infection.AIDS Res Ther. 2024 Mar 4;21(1):13. doi: 10.1186/s12981-024-00598-4. AIDS Res Ther. 2024. PMID: 38439093 Free PMC article.
-
Immune Dysregulation in Myocardial Fibrosis, Steatosis, and Heart Failure: Current Insights from HIV and the General Population.Curr HIV/AIDS Rep. 2021 Feb;18(1):63-72. doi: 10.1007/s11904-020-00536-9. Epub 2021 Jan 12. Curr HIV/AIDS Rep. 2021. PMID: 33433816 Review.
-
Myocardial steatosis across the spectrum of human health and disease.Exp Physiol. 2024 Feb;109(2):202-213. doi: 10.1113/EP091566. Epub 2023 Dec 8. Exp Physiol. 2024. PMID: 38063136 Free PMC article. Review.
References
-
- Cerrato E, D'Ascenzo F, Biondi-Zoccai G et al. . Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J 2013; 34:1432–6. - PubMed
-
- Onur I, Ikitimur B, Oz F et al. . Evaluation of human immunodeficiency virus infection-related left ventricular systolic dysfunction by tissue Doppler strain echocardiography. Echocardiography 2014; 31:1199–204. - PubMed
-
- Mondy KE, Gottdiener J, Overton ET et al. . High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy. Clin Infect Dis 2011; 52:378–86. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials